APEI

Rating neutralAI Memo

American Public Education

As of 2026-09-24/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-24 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q3 enrollment and profitability test • 2026-11-15

Base target: $45 / p=50% prob

Biggest risk

The Q3 outlook implies adjusted EBITDA below the $20.7 million reported a year earlier, while Q2 operating cash flow fell to $12.1 million from $14.8 million. Integration and campus expansion add execution risk. [#SEC-8K-2026-08-10]

Invalidation

Break below $30 or thesis failure.

What would change my mind?

Q2 revenue rose 5.5% to $171.7 million, adjusted EBITDA rose 36.8% to $20.7 million, and management raised FY2026 guidance. Continued Health+ enrollment growth and Military+ registrations could support the positive directional prior. [#SEC-8K-2026-08-10]

Research note

Recommendation

neutral

Confidence

medium

As of

2026-09-24

Base target

$45

p=50%

Bull target

$55

p=25%

Bear target

$30

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Health+ enrollment growth and institutional integration
Q2 revenue rose 5.5% to $171.7 million, adjusted EBITDA rose 36.8% to $20.7 million, and management raised FY2026 guidance.
Continued Health+ enrollment growth and Military+ registrations could support the positive directional prior.

BearKey bullets

An APUS officer reported an open-market sale of 8,800 shares on August 12; the filing does not establish a view on future operating results.
[#SEC-FORM4-2026-08-13]
Enrollment growth, tuition increases, the Orlando campus, and the completed institutional combination may not translate into sustained margins.

WatchKey bullets

Q3 enrollment and profitability test

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $45 (p=50%)

Target spread vs base: +22% / -33%

Scenario probabilities

Bull Target: $55 (p=25%)Base Target: $45 (p=50%)Bear Target: $30 (p=25%)

Commentary

Company-reported Q2 growth and raised guidance are constructive, but the weaker Q3 EBITDA outlook warrants caution. A September 9 Zacks recap said shares were down approximately 0.8% since the August earnings report; that is secondary reporting, not a current price-reaction measurement. No verified post-print target revisions, options skew, short-interest, employee, or social-sentiment measures were supplied. [#SEC-8K-2026-08-10] [#PR-EARNINGS-2026-09-09]

As of 2026-09-24 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Health+ enrollment growth and institutional integration

Scenarios

Bull Target (Scenario probability)

$55 / p=25% prob

Base Target (Scenario probability)

$45 / p=50% prob

Bear Target (Scenario probability)

$30 / p=25% prob

Analysis 2026-09-24 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-11-15
Q3 enrollment and profitability test
APEI projects 101,000–103,000 Military+ net registrations, approximately 19,100 Health+ students, and $14.0–$17.0 million of adjusted EBITDA for Q3. The next results will test whether enrollment growth offsets the projected year-over-year EBITDA decline. The reporting date has not been announced. [#8-K-2026-08-10] [#SEC-8K-2026-08-10]
Prob 80.00% • Move 7.00% • Priced-in 50.00%
EVENT2026-12-31
Delivery against raised FY2026 outlook
APEI raised its FY2026 outlook to $690–$698 million of revenue, $96–$104 million of adjusted EBITDA, and $2.48–$2.79 of diluted EPS. Year-end delivery is a more concrete test than extrapolating one strong quarter. [#SEC-8K-2026-08-10]
Prob 65.00% • Move 8.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

Health+ enrollment growth and institutional integration
2027-06-30
Health+ revenue grew 11.0% in Q2 on higher enrollment and modest tuition increases. APEI also reported opening an Orlando campus and completing the combination of its three institutions into one accredited institution. Sustained enrollment growth and effective integration could support earnings, but neither benefit is assured. [#SEC-8K-2026-08-10]
Prob 60% • Move 10% • Priced-in 45%

Risks

An APUS officer reported an open-market sale of 8,800 shares on August 12; the filing does not establish a view on future operating results. [#SEC-FORM4-2026-08-13]
Enrollment growth, tuition increases, the Orlando campus, and the completed institutional combination may not translate into sustained margins. [#SEC-8K-2026-08-10]
Q2 operating cash flow declined year over year despite higher revenue and earnings. [#SEC-8K-2026-08-10]
Q3 adjusted EBITDA guidance of $14.0–$17.0 million is below the $20.7 million reported for Q3 2025. [#SEC-8K-2026-08-10]

Peers

Symbol	Summary
LINC	A more relevant postsecondary-education operating comparator than the packet's same-sector, similar-market-cap restaurant, travel, and industrial candidates. No current peer valuation or operating metrics were supplied, so no quantitative multiple comparison is warranted.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-24

Loading AI feed…

Symbol

Summary

LINC

A more relevant postsecondary-education operating comparator than the packet's same-sector, similar-market-cap restaurant, travel, and industrial candidates. No current peer valuation or operating metrics were supplied, so no quantitative multiple comparison is warranted.